Genprex, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 30.86 million compared to USD 23.74 million a year ago. Basic loss per share from continuing operations was USD 22.56 compared to USD 19.8 a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.39 USD | +3.02% | -8.57% | -74.02% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-74.02% | 4.87M | |
+5.03% | 109B | |
+10.83% | 105B | |
-0.38% | 22.25B | |
-12.34% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-9.07% | 16.85B | |
+4.51% | 13.76B | |
+35.02% | 12.46B |
- Stock Market
- Equities
- GNPX Stock
- News Genprex, Inc.
- Genprex, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023